中文

兰卫医学 Revenue Breakdown

Period 2026-06-30 ・ Reported 2026-08-22

兰卫医学 reported revenue of ¥0.59B for the period ended 2026-06-30, -22.1% year on year. Net income was ¥0.07B, a 11.6% net margin on a 27.2% gross margin. The largest revenue line is 医学诊断服务 at 51% of the total. Free cash flow for the period was ¥0.04B.

ItemAmountY/Y
Revenue¥0.59B-22.1%
Gross profit¥0.16B
Operating income¥0.09B
Net income¥0.07B
Gross margin27.2%Net margin 11.6%
Revenue Q/Q+6.0%

Revenue Segments

SegmentRevenueShare
医学诊断服务¥0.30B51.0%
体外诊断产品销售¥0.29B48.8%
其他(补充)¥0.00B0.2%

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.43B72.8%
R&D¥0.02B2.9%
SG&A¥0.11B18.0%
Tax & other¥0.02B2.8%

Balance sheet & cash flow

ItemAmount
Total assets¥2.15B
Total liabilities¥0.51B
Shareholders' equity¥1.64B
Equity / assets76.3%
Operating cash flow¥0.05B
Capital expenditure¥0.01B
Free cash flow¥0.04B
Cash conversion (OCF / net income)223%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

匠心家居上海艾录海锅股份本立科技万事利显盈科技大地海洋凯盛新材开勒股份力量钻石中捷精工君亭酒店

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies